Intravascular large B-cell lymphoma masquerading as stroke successfully treated with R-Hyper-CVAD
-
Published:2024
Issue:
Volume:21
Page:100401
-
ISSN:2213-0489
-
Container-title:Leukemia Research Reports
-
language:en
-
Short-container-title:Leukemia Research Reports
Author:
Popiolek Christopher,
Gupta Kanchan,
Huff Mallorie L.,
Gupta RanjuORCID
Subject
Oncology,Hematology
Reference21 articles.
1. Intravascular large B-cell lymphoma in the United States (US): a population-based study using surveillance, epidemiology, and end results program and national cancer database;Rajyaguru;Leuk. Lymphoma,2017
2. Intravascular lymphoma: a neoplasm of 'homeless' lymphocytes?;Ponzoni;Hematol. Oncol.,2006
3. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks;Ponzoni;Blood,2018
4. Prognosis of Intravascular large B cell lymphoma (IVLBCL): analysis of 182 patients from global case series;Liu;Cancer Manag. Res.,2020
5. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial;Shimada;Lancet Oncol.,2020